Cardio Diagnostics Holdings Stock Price on October 31, 2024
CDIOW Stock | USD 0.1 0 2.10% |
If you're considering investing in Cardio Stock, it is important to understand the factors that can impact its price. As of today, the current price of Cardio Diagnostics stands at 0.1, as last reported on the 22nd of December, with the highest price reaching 0.10 and the lowest price hitting 0.08 during the day. Cardio Diagnostics is out of control given 3 months investment horizon. Cardio Diagnostics secures Sharpe Ratio (or Efficiency) of 0.19, which signifies that the company had a 0.19% return per unit of risk over the last 3 months. We were able to break down and interpolate data for twenty-nine different technical indicators, which can help you to evaluate if expected returns of 4.29% are justified by taking the suggested risk. Use Cardio Diagnostics Mean Deviation of 14.22, risk adjusted performance of 0.1507, and Downside Deviation of 17.63 to evaluate company specific risk that cannot be diversified away.
Cardio Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Cardio |
Sharpe Ratio = 0.1946
Best Portfolio | Best Equity | CDIOW | ||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns |
Estimated Market Risk
22.06 actual daily | 96 96% of assets are less volatile |
Expected Return
4.29 actual daily | 85 85% of assets have lower returns |
Risk-Adjusted Return
0.19 actual daily | 15 85% of assets perform better |
Based on monthly moving average Cardio Diagnostics is performing at about 15% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Cardio Diagnostics by adding it to a well-diversified portfolio.
Book Value 0.144 | Shares Float 20.8 M | Shares Short Prior Month 15.4 K | Shares Short 13 K | Revenue Per Share 0.002 |
Related Headline
Arcus Biosciences Headline on 31st of October 2024
Regeneron Tops Q3 Earnings and Revenue Estimates by zacks.com
Regeneron delivered earnings and revenue surprises of 6.04 percent and 1.31, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock
Cardio Diagnostics Valuation on October 31, 2024
It is possible to determine the worth of Cardio Diagnostics on a given historical date. On October 31, 2024 Cardio was worth 0.035 at the beginning of the trading date compared to the closed value of 0.038. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Cardio Diagnostics stock. Still, in general, we apply an absolute valuation method to find Cardio Diagnostics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Cardio Diagnostics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Cardio Diagnostics' related companies.
Open | High | Low | Close | Volume | |
0.03 | 0.04 | 0.03 | 0.04 | 301.00 | |
10/31/2024 | 0.04 | 0.04 | 0.03 | 0.04 | 7,332 |
0.04 | 0.04 | 0.04 | 0.04 | 3,600 |
Backtest Cardio Diagnostics | | | Cardio Diagnostics History | | | Cardio Diagnostics Valuation | Previous | Next |
Cardio Diagnostics Trading Date Momentum on October 31, 2024
On November 01 2024 Cardio Diagnostics Holdings was traded for 0.04 at the closing time. The highest daily price throughout the period was 0.04 and the lowest price was 0.04 . The daily volume was 3.6 K. The net trading volume on 11/01/2024 did not affect price variability. The overall trading delta to current closing price is 32.37% . |
Cardio Diagnostics Fundamentals Correlations and Trends
By evaluating Cardio Diagnostics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Cardio Diagnostics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Cardio financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Cardio Diagnostics Stock history
Cardio Diagnostics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Cardio is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Cardio Diagnostics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Cardio Diagnostics stock prices may prove useful in developing a viable investing in Cardio Diagnostics
Cardio Diagnostics Inc. develops and manufactures a genetic and epigenetic based test for prevention and detection of cardiovascular disease. Cardio Diagnostics Inc. was founded in 2017 and is based in Chicago, Illinois. Cardio Diagnostics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Cardio Diagnostics Quarterly Net Working Capital |
|
Cardio Diagnostics Stock Technical Analysis
Cardio Diagnostics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Cardio Diagnostics Period Price Range
Low | December 22, 2024
| High |
0.00 | 0.00 |
Cardio Diagnostics Holdings cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Cardio Diagnostics December 22, 2024 Market Strength
Market strength indicators help investors to evaluate how Cardio Diagnostics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cardio Diagnostics shares will generate the highest return on investment. By undertsting and applying Cardio Diagnostics stock market strength indicators, traders can identify Cardio Diagnostics Holdings entry and exit signals to maximize returns
Cardio Diagnostics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Cardio Diagnostics' price direction in advance. Along with the technical and fundamental analysis of Cardio Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Cardio to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | 0.1507 | |||
Jensen Alpha | 3.82 | |||
Total Risk Alpha | 3.19 | |||
Sortino Ratio | 0.2133 | |||
Treynor Ratio | (2.19) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.